Nanotech-Based Medicines Nearing Commercialization

    NEW YORK, Jan. 12 /PRNewswire-USNewswire/ -- Innovations at the
 intersection of medicine, biotechnology, engineering, physical sciences and
 information technology are spurring new directions in R&D,
 commercialization and technology transfer. Basic research in nanomedicine
 and bionanotechnology is rapidly producing commercially viable products.
 Governments and industries across the globe are staking their claims by
 investing billions for research. Clearly, international rivalries are
 growing and political alliances and battle lines are beginning to gel.
     The nanotech community will gather at ALM's Strategic Research
 Institute's "2nd Annual NANOMEDICINE: Commercializing Drug Delivery,
 Diagnostics and Medical Devices" conference for two days on March 26-27,
 2007 in Arlington, VA to discuss the most important applications of
 nanotechnology in drug delivery, diagnostics and medical devices. The
 two-day event will consist of presentations, panels and networking
 opportunities, providing insights into trends in nanomedicine, dissociating
 myths from realities and highlighting future areas of commercial potential.
 The previous conference was so successful that a front-page lead cover
 story covering the conference appeared in Genetic Engineering News.
     The 2007 event will focus on cutting-edge R&D, commercialization
 strategies, policy, regulatory and IP issues -- offering networking
 opportunities to researchers from industry, government and academia;
 physicians; intellectual property practitioners; business and economic
 development professionals; technology transfer specialists, policy makers
 and venture capitalists.
     For more information on registration, potential speaking engagements,
 or sponsorship/exhibition opportunities, please contact the organizer, Jon
 E. Liong of Strategic Research Institute at jliong@srinstitute.com or call
 (212)967-0095 ext. 243. The conference website is www.srinstitute.com/nano.
     ABOUT STRATEGIC RESEARCH INSTITUTE
     The Strategic Research Institute is part of ALM's Conference and Trade
 Show Division, one of North America's largest producers of educational and
 networking events for business leaders and the legal profession. The
 division offers more than 300 conferences and two leading industry
 tradeshows, as well as conferences in Europe and Asia. Attendance at the
 division's events, which span a broad range of topics including law,
 finance, natural resources, life sciences, multi-cultural marketing, real
 estate and healthcare, will exceed 40,000 executive-level decision makers
 this year.
     ABOUT ALM
     Headquartered in New York City, ALM is a leading integrated media
 company, focused on the legal and business communities. ALM currently owns
 and publishes 37 national and regional magazines and newspapers, including
 The American Lawyer(R), Corporate Counsel(R), The National Law Journal(R)
 and Real Estate Forum(R). Other ALM businesses include Law.com(R), the
 Web's leading legal news and information network, Law Journal Press books,
 newsletter publishing, court verdict and settlement reporting, production
 of professional educational seminars, market research and content
 distribution. ALM was formed by U.S. Equity Partners, L.P., a private
 equity fund sponsored by Wasserstein & Co., LP. More information on ALM's
 businesses and services is available on the Web at www.alm.com.
 
 

SOURCE Strategic Research Institute

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.